BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16002741)

  • 1. Rho-kinase is an important therapeutic target in cardiovascular medicine.
    Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress of the study of rho-kinase and future perspective of the inhibitor.
    Tawara S; Shimokawa H
    Yakugaku Zasshi; 2007 Mar; 127(3):501-14. PubMed ID: 17329936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
    Budzyn K; Marley PD; Sobey CG
    Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
    Hu E; Lee D
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
    Jalil J; Lavandero S; Chiong M; Ocaranza MP
    Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells.
    Hiroki J; Shimokawa H; Mukai Y; Ichiki T; Takeshita A
    Biochem Biophys Res Commun; 2005 Jan; 326(1):154-9. PubMed ID: 15567165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells.
    Hiroki J; Shimokawa H; Higashi M; Morikawa K; Kandabashi T; Kawamura N; Kubota T; Ichiki T; Amano M; Kaibuchi K; Takeshita A
    J Mol Cell Cardiol; 2004 Aug; 37(2):537-46. PubMed ID: 15276023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm.
    Kandabashi T; Shimokawa H; Miyata K; Kunihiro I; Eto Y; Morishige K; Matsumoto Y; Obara K; Nakayama K; Takahashi S; Takeshita A
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2209-14. PubMed ID: 14592852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
    Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
    Calò LA; Pessina AC
    J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
    Shimokawa H
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):319-27. PubMed ID: 11862109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular protective action of Rho-kinase inhibitors].
    Hirooka Y
    Nihon Rinsho; 2004 Jan; 62(1):161-71. PubMed ID: 14737849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rho-Rho kinase pathway].
    Takuwa Y
    Nihon Rinsho; 2004 Jan; 62(1):43-8. PubMed ID: 14737834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rho and Rho-kinase].
    Sato J; Iiri T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():197-202. PubMed ID: 16897863
    [No Abstract]   [Full Text] [Related]  

  • 20. Rho/Rho-kinase mediated signaling in physiology and pathophysiology.
    Wettschureck N; Offermanns S
    J Mol Med (Berl); 2002 Oct; 80(10):629-38. PubMed ID: 12395147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.